Platelet-Membrane-Encapsulated Carvedilol with Improved Targeting Ability for Relieving Myocardial Ischemia–Reperfusion Injury
In recent years, cell membrane drug delivery systems have received increasing attention. However, drug-loaded membrane delivery systems targeting therapy in myocardial ischemia–reperfusion injury (MIRI) have been relatively rarely studied. The purpose of this study was to explore the protective effe...
Main Authors: | Tingting Zhou, Xuechao Yang, Tianyi Wang, Mingming Xu, Zhanghao Huang, Runze Yu, Yi Jiang, Youlang Zhou, Jiahai Shi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Membranes |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0375/12/6/605 |
Similar Items
-
The effects of carvedilol on ischemia-reperfusion injury in the rat testis
by: B.S. Parlaktas, et al.
Published: (2014-01-01) -
Matrix Metalloproteinase-2 Inhibition in Acute Ischemia-Reperfusion Heart Injury—Cardioprotective Properties of Carvedilol
by: Monika Skrzypiec-Spring, et al.
Published: (2021-12-01) -
Transfersome Encapsulated with the R-carvedilol Enantiomer for Skin Cancer Chemoprevention
by: Md Abdullah Shamim, et al.
Published: (2023-03-01) -
BETA-ADRENOBLOCKERS AND PLATELET AGGREGATION. CARVEDILOL
by: A. N. Zakirova, et al.
Published: (2016-01-01) -
A simple LC-MS/MS method for pharmacokinetic study of carvedilol and 4/-hydroxyphenyl carvedilol at a low dose
by: Wanna Eiamart, et al.
Published: (2022-01-01)